GlobalData on MSN19h
Eli Lilly pays $10m upfront for Organovo’s FXR agonist
Eli Lilly (Lilly) has agreed to make a $10m upfront payment for full worldwide rights to San Diego-based Organovo Holdings’ ...
FierceBiotech22h
Eli Lilly buys Organovo's FXR program for $10M, sending biotech's stock skyrocketing 244%
Eli Lilly has acquired Organovo’s lead asset, a clinical FXR agonist designed to treat inflammatory bowel disease (IBD), in a ...
Crypto Data Space Teknoloji ve Medya Anonim Åžirketi22h
Onvo Stock- Eli Lilly Boosts Organovo’s Value with FXR Program Buyout
Onvo Stock- Organovo's stock jumps 200% after Eli Lilly acquires its FXR program, including the promising IBD treatment ...
MT Newswires on MSN12h
Eli Lilly Plans 4 New US Manufacturing Sites With $27 Billion Investment
Eli Lilly (LLY) on Wednesday outlined a plan to invest at least $27 billion to build four new pharmaceutical manufacturing sites in the US. The pharmaceutical giant said that three of the planned ...